BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Ji‐Kai Liu"”

4 results

Genome-wide analysis of WRKY transcription factors in Solanum lycopersicum

Verified

Shengxiong Huang, Yongfeng Gao, Ji‐Kai Liu, Xiaoli Peng et al.

Journal: Molecular Genetics and GenomicsYear: 2012Citations: 449

The WRKY transcription factors have been implicated in multiple biological processes in plants, especially in regulating defense against biotic and abiotic stresses. However, little information is available about the WRKYs in tomato (Solanum lycopersicum). The recent release of the whole-genome sequ...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular Biology
Read Source

Nuclear and membrane estrogen receptor antagonists induce similar <scp>mTORC</scp>2 activation‐reversible changes in synaptic protein expression and actin polymerization in the mouse hippocampus

Verified

Fangzhou Xing, Yan‐Gang Zhao, Yuanyuan Zhang, He Li et al.

Journal: CNS Neuroscience & TherapeuticsYear: 2018Citations: 31

AIMS: Estrogens play pivotal roles in hippocampal synaptic plasticity through nuclear receptors (nERs; including ERα and ERβ) and the membrane receptor (mER; also called GPR30), but the underlying mechanism and the contributions of nERs and mER remain unclear. Mammalian target of rapamycin complex 2...

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity

Verified

Feng Ji, Kai Yan, Bo Ding, Yuxin Zhu et al.

Journal: OncogeneYear: 2025Citations: 1

Ovarian cancer (OC) remains a lethal malignancy with limited treatment options owing to antigen heterogeneity and an immunosuppressive tumor microenvironment (TME). Here, we designed a unique chimeric Antigen Receptor T-Cell (CAR-T) construct (B4M3) that integrates an anti-MSLN scFv linked to the CD...

Health SciencesMedicineOncology
Read Source

Dual-Target CAR-T Therapy for Ovarian Cancer: Synergistic Targeting of MSLN and B7H3 Enhances Anti-Tumor Efficacy and Overcomes Antigen Heterogeneity

Verified

Feng Ji, Kai Yan, Bo Ding, Yuxin Zhu et al.

Journal: SSRN Electronic JournalYear: 2025
Health SciencesMedicineOncologyOpen Access
Read Source
PreviousPage 1 of 1Next